Literature DB >> 2432375

A small, removable microdialysis probe.

L Hernandez, B G Stanley, B G Hoebel.   

Abstract

A miniaturized, concentric, microdialysis probe is described. It is constructed from 36 gauge stainless steel tubing inside of 26 gauge tubing, with a cellulose hollow fiber tip 0.2 mm in diameter and 2 mm long. It has a 6000 molecular weight cut off that excludes enzymes but collects monoamines, their metabolites, and other small neurochemicals. In vitro tests show relative recovery rates of 5-10%. Absolute recovery measured in picograms was independent of the perfusate flow rate inside the probe. Tests in awake rats with probes in the nucleus accumbens showed stable amounts of catecholamines and metabolites collected during repeated 20 min samples. After ip amphetamine, release of dopamine in the accumbens increased from 20 to 40 pg per sample while DOPAC and HVA decreased from about 1500 to 500 pg. Tests of multiple site sampling succeeded in obtaining norepinephrine and dopamine plus three metabolites (DOPAC, HVA and 5HIAA) from four probes simultaneously in four different brain sites in each rat. Five day continuous samples or monthly intermittent samples can be obtained with this microdialysis probe.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432375     DOI: 10.1016/0024-3205(86)90119-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet.

Authors:  Pedro Rada; Miriam E Bocarsly; Jessica R Barson; Bartley G Hoebel; Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2010-07-16

Review 2.  In vivo monitoring of brain neurotransmitter release for the assessment of neuroendocrine interactions.

Authors:  M Mas; J L Gonzalez-Mora; L Hernandez
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

Review 3.  Brain microdialysis in exercise research.

Authors:  R Meeusen; M F Piacentini; K De Meirleir
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis.

Authors:  T Baptista; L Teneúd; Q Contreras; J L Burguera; M Burguera; L Hernández
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.

Authors:  Pedro Rada; Jessica R Barson; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

6.  Effects of reserpine on dopamine metabolite in the nucleus accumbens and locomotor activity in freely moving rats.

Authors:  R Sugita; Y Sawa; S Nomura; S H Zorn; T Yamauchi
Journal:  Neurochem Res       Date:  1989-03       Impact factor: 3.996

7.  Bidirectional microdialysis in vivo shows differential dopaminergic potency of cocaine, procaine and lidocaine in the nucleus accumbens using capillary electrophoresis for calibration of drug outward diffusion.

Authors:  L Hernandez; N A Guzman; B G Hoebel
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity.

Authors:  B M Geiger; M Haburcak; N M Avena; M C Moyer; B G Hoebel; E N Pothos
Journal:  Neuroscience       Date:  2009-02-11       Impact factor: 3.590

9.  (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat.

Authors:  Maia Terashvili; Hsiang-En Wu; Emma T Schwasinger; Kuei-Chun Hung; Jau-Shyong Hong; Leon F Tseng
Journal:  Eur J Pharmacol       Date:  2008-03-29       Impact factor: 4.432

10.  Underweight rats have enhanced dopamine release and blunted acetylcholine response in the nucleus accumbens while bingeing on sucrose.

Authors:  N M Avena; P Rada; B G Hoebel
Journal:  Neuroscience       Date:  2008-08-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.